Abstract
A Single Inhaler Combining a Corticosteroid and Long-Acting Beta-2 Agonist for Maintenance with Additional Doses for Reliever Therapy (SMART): Obstacles for Asthma Patients in the USA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have